Literature DB >> 30933361

A Positive Feedback Loop Between Cancer Stem-Like Cells and Tumor-Associated Neutrophils Controls Hepatocellular Carcinoma Progression.

Shao-Lai Zhou1,2,3, Dan Yin1,2,3, Zhi-Qiang Hu1,2,3, Chu-Bin Luo1,2,3, Zheng-Jun Zhou1,2,3, Hao-Yang Xin1,2,3, Xin-Rong Yang1,2,3, Ying-Hong Shi1,2,3, Zheng Wang1,2,3, Xiao-Wu Huang1,2,3,4, Ya Cao5,6, Jia Fan1,2,3,4,7, Jian Zhou1,2,3,4,7.   

Abstract

Tumor-associated neutrophils (TANs) play a crucial role in tumor development and progression in the cancer microenvironment. Despite increased understanding of TAN contributions to hepatocellular carcinoma (HCC) progression and prognosis, the direct interaction between TANs and HCC cells is not fully understood. In this study, we tested the effect of TANs on HCC cells in vitro and in vivo and investigated the mechanism of interaction between them. Our results showed that TANs secreted bone morphogenetic protein 2 and transforming growth factor beta 2 and triggered microRNA 301b-3p (miR-301-3p) expression in HCC cells, subsequently suppressed gene expression of limbic system-associated membrane protein (LSAMP) and CYLD lysine 63 deubiquitinase (CYLD), and increased stem cell characteristics in HCC cells. These TAN-induced HCC stem-like cells were hyperactive in nuclear factor kappa B signaling, secreted higher levels of chemokine (C-X-C motif) ligand 5 (CXCL5), and recruited more TAN infiltration, suggesting a positive feedback loop. In clinical HCC samples, increased TANs correlated with elevated miR-301b-3p, decreased LSAMP and CYLD expression, and increased nuclear p65 accumulation and CXCL5 expression, all of which predicted patient outcome.
Conclusion: Our work identified a positive feedback loop governing cancer stem-like cells and TANs in HCC that controls tumor progression and patient outcome.
© 2019 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30933361     DOI: 10.1002/hep.30630

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  53 in total

Review 1.  Neutrophils as potential therapeutic targets in hepatocellular carcinoma.

Authors:  Daniel Geh; Jack Leslie; Rob Rumney; Helen L Reeves; Thomas G Bird; Derek A Mann
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-01-12       Impact factor: 46.802

Review 2.  Hepatocellular Carcinoma Tumor Microenvironment and Its Implications in Terms of Anti-tumor Immunity: Future Perspectives for New Therapeutics.

Authors:  Basri Satilmis; Tevfik Tolga Sahin; Egemen Cicek; Sami Akbulut; Sezai Yilmaz
Journal:  J Gastrointest Cancer       Date:  2021-10-08

3.  Associations among the mutational landscape, immune microenvironment, and prognosis in Chinese patients with hepatocellular carcinoma.

Authors:  Zhi-Qiang Hu; Hao-Yang Xin; Chu-Bin Luo; Jia Li; Zheng-Jun Zhou; Ji-Xue Zou; Shao-Lai Zhou
Journal:  Cancer Immunol Immunother       Date:  2020-08-06       Impact factor: 6.968

4.  Candesartan ameliorates vascular smooth muscle cell proliferation via regulating miR-301b/STAT3 axis.

Authors:  Ling Zhang; Fan Yang; Qiong Yan
Journal:  Hum Cell       Date:  2020-03-13       Impact factor: 4.174

Review 5.  Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade.

Authors:  Amber G Bozward; Frazer Warricker; Ye H Oo; Salim I Khakoo
Journal:  Front Immunol       Date:  2021-04-30       Impact factor: 7.561

6.  Characterization of immune infiltration in sarcomatoid hepatocellular carcinoma.

Authors:  Chubin Luo; Haoyang Xin; Dan Yin; Tongyi Zhao; Zhiqiang Hu; Zhengjun Zhou; Rongqi Sun; Na Yao; Qiman Sun; Jia Fan; Xiaowu Huang; Jian Zhou; Shaolai Zhou
Journal:  Aging (Albany NY)       Date:  2021-06-03       Impact factor: 5.682

Review 7.  Cancer stem cell-immune cell crosstalk in tumour progression.

Authors:  Defne Bayik; Justin D Lathia
Journal:  Nat Rev Cancer       Date:  2021-06-08       Impact factor: 60.716

Review 8.  Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review.

Authors:  Kyoko Oura; Asahiro Morishita; Joji Tani; Tsutomu Masaki
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

9.  The Crosstalk Between Cancer Cells and Neutrophils Enhances Hepatocellular Carcinoma Metastasis via Neutrophil Extracellular Traps-Associated Cathepsin G Component: A Potential Therapeutic Target.

Authors:  Xiangqian Guan; Yuyan Lu; Heping Zhu; Shuqi Yu; Wenxiu Zhao; Xiaoqin Chi; Chengrong Xie; Zhenyu Yin
Journal:  J Hepatocell Carcinoma       Date:  2021-05-20

10.  Construction and validation of a prognostic signature using CNV-driven genes for hepatocellular carcinoma.

Authors:  Jin Bian; Junyu Long; Xu Yang; Xiaobo Yang; Yiyao Xu; Xin Lu; Mei Guan; Xinting Sang; Haitao Zhao
Journal:  Ann Transl Med       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.